论文部分内容阅读
目的:分析少白细胞输血技术降低输血不良反应的临床效果,探讨少白细胞输血技术的临床效果。方法:选取2015年6月至2016年6月惠州市中心血站搜集的530例需要输血患者分为两组,观察组患者采用少白细胞输血技术,对照组患者采用常规输血技术,将两组患者的不良反应发生率进行对比。结果:观察组的不良反应发生率3.77%显著低于对照组的11.32%,差异具有统计学意义(P<0.05)。结论:少白细胞输血技术在输血过程中能有效降低输血不良反应情况发生,增加对危重患者的抢救效果。
Objective: To analyze the clinical effect of leukocyte transfusion to reduce adverse reactions of transfusion and to explore the clinical effect of leukocyte transfusion. Methods: From June 2015 to June 2016, 530 blood transfusion patients collected from Huizhou Blood Center were divided into two groups. The observation group received leukocyte transfusion and the control group received routine blood transfusion. Two groups of patients Adverse reaction rates were compared. Results: The incidence of adverse reactions in the observation group was significantly lower than that in the control group (3.77% vs 11.32%, P <0.05). Conclusion: Leukocyte transfusion technology can effectively reduce the incidence of transfusion adverse reactions during transfusion and increase the rescue effect for critically ill patients.